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Abstract. This paper presents a novel machine learning approach to per-9
form an early prediction of the healthcare cost of breast cancer patients. The10
learning phase of our prediction method considers the following two steps: i) in11
the first step, the patients are clustered taking into account the sequences of ac-12
tions undergoing similar clinical activities and ensuring similar healthcare costs,13
and ii) a Markov chain is then learned for each group to describe the action-14
sequences of the patients in the cluster. A two step procedure is undertaken in15
the prediction phase: i) first, the healthcare cost of a new patient’s treatment16
is estimated based on the average healthcare cost of its k≠nearest neighbors in17
each group, and ii) finally, an aggregate measure of the healthcare cost estimated18
by each group is used as the final predicted cost. Experiments undertaken reveal19
a mean absolute percentage error as small as 6%, even when half of the clinical20
records of a patient is available, substantiating the early prediction capability of21
the proposed method. Comparative analysis substantiates the superiority of the22
proposed algorithm over the state-of-the-art techniques.23
24
Keywords: Healthcare Cost, Clustering, Markov Chain, k Nearest25
Neighbor.26
1 Introduction27
An electronic health record (EHR) is an electronic version of a patient’s clinical28
history over time. It comprises all administrative clinical data of a patient in a29
healthcare organization, including his/her demographics, diagnosis, medications,30
laboratory data, and associated costs, and so on. The plethora of longitudinal31
patients’ data of an EHR can be utilized for developing patient-centered per-32
sonalized healthcare solutions, including cost. It is however worth mentioning33
that the healthcare costs, ranging from clinician’s fees to the cost of hospital34
stays and medicines, are escalating at a rapid rate around the world [1] [2]. It35
has motivated the researchers to take keen interest in controlling this upsurge36
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in the healthcare costs. The crucial step to control the healthcare cost is to37
enable the healthcare organizations to predict the possible future cost of indi-38
vidual patients. It in turn helps to identify the individuals at the highest risk of39
enduring the significant costs in future. It thus helps to prioritize the allocation40
of scarce resources among the patients in a healthcare organization for e cient41
care management.42
Moreover, a report from The Commonwealth Fund (2012) emphasizes the43
need to identify high-cost patients as the first step towards achieving “rapid44
improvements in the value of services provided” [22]. A proactive approach to45
address this problem is to identify patients who are at risk of becoming high-cost46
patients accurately before substantial unnecessary costs have been incurred and47
health condition has deteriorated further. Eventually, this calls for prediction48
of possible total healthcare cost of a patient as early as possible when a limited49
volume of clinical records of the given patient is provided. In other words,50
another important aspect in the context of healthcare cost prediction is to devise51
a model using a training set of complete clinical records of some patients to52
predict the total healthcare cost of a new patient as accurately and also as53
early as possible, preferably before the availability of the patient’s full-length54
clinical record. Such early prediction of future healthcare cost can be used to55
judiciously identify high-risk high-cost patients and prevent crises in healthcare56
organizations. It is obvious that the earliness of the prediction may a ect the57
accuracy. It has motivated the researchers to build a model to predict healthcare58
cost as early as possible while maintaining an appropriate level of accuracy.59
Nevertheless, healthcare cost prediction based on individual patient’s char-60
acteristics is a challenging issue from the data mining perspective due to the61
non-Gaussian skewed distribution of the cost data of the patients [5]. Studies in62
[6], [7] reveal dubious e cacy of the statistical methods to predict the healthcare63
cost. Furthermore, the traces of linear regression and rule-based approaches are64
also found in literature [2], [7] for the cost prediction. But the requirement of65
a lot of domain knowledge has restricted their applications for most of the real66
world economic data of the patients [8]. Now-a-days, machine learning algo-67
rithms, including clustering and classification techniques, have emerged as an68
alternative e ective tool for this purpose [9], [10].69
This paper proposes a machine learning based novel approach for healthcare70
cost prediction of individual patient’s treatments based on their clinical actions,71
jointly including the clinical activities and the respective cost over time. The72
activity here represents diagnosis, medication, pharmacy and the like. A two-73
step procedure is employed in the learning phase: i) in the first step, the ordered74
sequences of clinical actions of the patients’ treatments are clustered using the75
hierarchical DBSCAN [15] with an aim to identify the group of patients under-76
taking similar clinical activities and incurring similar healthcare costs, and ii)77
each group is then modelled by means of a Markov chain [11] delineating the78
probability distributions of transitions between di erent clinical actions. A new79
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distance measure is also proposed to measure the similarity of the treatment80
patterns of the patients during clustering.81
The prediction phase, concerned with prediction of the healthcare cost of the82
sequence of clinical actions of a new patient’s treatment, also encompasses two83
steps: i) first, for each group, we compute a tentative cost of the new sequence84
by averaging the cost of its k-nearest neighbor [12] sequences in the group, ii)85
the final cost is obtained as a weighted sum of the cost estimated by each of the86
groups. The weights for each group are the likelihood of the new sequence to87
the respective group as assigned by the corresponding Markov chain.88
The performance of the proposed healthcare cost prediction algorithm is eval-89
uated with the economic information together with information of the clinical90
activities of the breast cancer patients obtained from the health administrative91
department of the public health care system of the Basque Country, Spain. A 10-92
fold cross validation is employed with the training dataset resulting the optimal93
value of k of k-NN as three in the present application with respect to the mean94
absolute percentage error (MAPE) [2]. Moreover, the proposed method results95
in an MAPE measure of less than 6% when half of the clinical records of a new96
patient is available, irrespective of the value of k. It substantiates the capability97
of the proposed stratagem for early prediction of healthcare cost. Experiments98
undertaken also reveal that the proposed algorithm outperforms its state-of-the-99
art contenders with respect to MAPE metric. The comparative analyses verify100
the significance of jointly considering the clinical activity and the associated cost101
data to e ectively capture the clinical records of patients for accurate healthcare102
cost prediction as early as possible.103
The paper is divided into following sections. Section 2 delineates the proposed104
method of healthcare cost prediction. Experiments undertaken and the results105
are reported in Section 3. Section 4 concludes the paper.106
2 Method107
2.1 Data Transformation108
This section refers to transforming the database of individual patient’s treat-109
ments into a series of actions, sorted by time. Here, we provide some definitions110
which will be used throughout the paper to develop a solution to the healthcare111
cost prediction problem.112
Definition-1: Action. Let X be the set of all clinical activities, including113
diagnosis, procedure, medicine and the like, Y œ R be the set of all possible114
incurred healthcare cost as recorded in the database and T be the set of visiting115
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times of the patients to the hospital. An action, say a, is then expressed as a116
three-tuple, given by117
a = {( x, y, t) |’x œ X, ’y œ Y, ’t œ T}. (1)
Definition-2: Patient’s treatment. A patient’s treatment is defined by a118
sequence of its corresponding actions, sorted by the visiting time. Symbolically,119
a patient’s treatment P is represented by120
P = (a1, a2, ..., an) (2)
where ai = (xi, yi, ti) represents the action encompassing the clinical activity121
xi œ X and its respective healthcare cost yi œ Y incurred during visiting time122
ti œ T of the specific patient. For sake of simplicity of readers, we drop the123
notion of visiting time and hence ai now can be simplified as124
ai = {( xi, yi) |x œ X, y œ Y}. (3)
The clinical actions of P in (2) are chronologically ordered. Evidently, if125
i < j, ai occurs before aj . A sequence of actions of a patient’s treatment is used126
to jointly track the progression of its activity-outcome and the corresponding127
healthcare cost over time. The length of the sequence varies across patients128
because of the diversity in their treatments over time.129
Definition-3: Modified cost. Intuitively, the number of possible actions130
for all patients in the database is huge due to infinite number of healthcare cost131
elements in Y. For the sake of simplicity, Y is reduced to a finite set in a two132
step procedure described below.133
1) Discretization: First, the entire range of Y is discretized into ns segments134
defined by the ns-quantiles of Y. In other words, we set the lower and the135
upper limit of the i-th segment respectively to the (i ≠ 1)-th quantile and the136
i-th quantile of the healthcare cost elements for all possible clinical activities,137
recorded in the database.138
2) Quantization: Then a real healthcare cost element, lying in the i-th seg-139
ment is replaced by the mean value of all cost elements of the i-th segment.140
The strategy is pictorially demonstrated in Fig. 1 for the healthcare cost141
information of two patients only with ns = 8. The setting of ns = 8 and the cost142
values used here are illustrative examples only. The healthcare cost, referred143
henceforth, denotes the modified cost.144
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Figure 1: Calculation of modified healthcare cost of two patients with 8-quantiles
2.2 Clustering Patients’ Action-Sequences145
It is noteworthy that patients undergoing various clinical activities reveal consid-146
erable diversity of their corresponding cost information. Hence, prior to predict147
cost of a new action-sequence, we cluster the action-sequences of the existing148
patients into groups. We then consult the cost information of the specific group149
of patients providing the maximum similarity with the action-sequence of the150
new patient to predict the respective possible future cost.151
Two significant issues to categorize the patients based on their action se-152
quences include: i) design of an appropriate distance measure to capture the153
similarity between action-sequences of varying length, and ii) selection of an ef-154
ficient clustering algorithm to ensure that action-sequences within a group are155
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similar to each other than those in other groups.156
Design of distance measure: There exists plethora of literature on us-157
ing edit distance [13] to measure the dissimilarity of two strings of characters158
(or words). Given two strings S1 and S2 over a finite alphabet, an edit dis-159
tance ED(S1, S2) between S1 and S2 can be defined as the minimum cost of160
transforming S1 to S2 through a sequence of weighted edit operations. These161
operations primarily include insertion, deletion, and substitution of one symbol162
by another. Usually, the edit operations are assigned with equal weights of unity.163
Nevertheless, the string in this paper denotes the action-sequences.164
However, there is a major limitation of using the conventional ED directly165
in the present context. The conventional ED compares two strings of characters166
(or words) only. In the present work, the components of the string (or action-167
sequence) is not only representing character (symbolizing a clinical activity)168
but an activity-cost pair. Hence, application of the conventional ED in the169
present scenario captures the di erence between two action-sequences based on170
their respective clinical activities only, ignoring the corresponding healthcare cost171
information. It thus loses the cost information and the temporal relationship of172
the activity-cost pairs over time.173
Consequently, the clusters of patients based on the conventional ED measures174
identify patients ensuring similar clinical activities only. Evidently, the accuracy175
of the healthcare cost prediction based on the clusters, thus formed, is reduced to176
great extent. It has motivated us to design an appropriate distance measure to177
jointly capture the dissimilarity of two clinical activities (of two di erent action178
sequences) and their respective healthcare costs.179
The proposed distance measure, referred to as treatment pattern di erence180
(TPD) is an extended version of the conventional ED. In case of the conventional181
ED, all possible edit operations are associated with equal cost of unity. In TPD,182
the edit costs are modified as follows to consider the healthcare cost components183
of two action-sequences.184
Let P1 and P2 be two di erent action-sequences. The cost of insertion of a185
clinical activity xi (or a character) to convert P2 to P1 is given by186
C1 = yi (4)
where yi denotes the healthcare cost of the clinical activity xi at the visiting187
time ti in the action-sequence P1. Similarly, the cost of deleting an action xj188
from P1 to covert it to P2 is given by189
C2 = yj (5)
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where the symbols carry their usual meanings. If the clinical activity xi of P1190
is substituted with a di erent clinical activity xj of P2, the corresponding edit191
cost is given by192
C3 = |yi ≠ yj + ‘|. (6)
Here ‘ is a small positive constant. It is used to ensure that even when yi = yj193
for xi ”= xj , at least C3 = ‘ is used as the edit cost for substitution of xi by xj .194
It is noteworthy that if xi = xj , the conventional ED gives a zero penalty.195
However, there are instances of di erent healthcare costs for the same clinical196
activity of two di erent patients. To capture this, TPD uses an additional edit197
cost, given by198
C4 = |yi ≠ yj |. (7)
Hence, the total edit cost to convert an action-sequence P1 to another action-199
sequence P2 is given by200













Here, w1 and w2 denote the weight for the edit operations respectively for201
di erent and similar activities. Intuitively, w2 < w1 as it corresponds to the202
penalty corresponding to similar activities with di erent healthcare cost. After203
a wide experimentation, we set w1 = 0.7 and w2 = 0.3. An example of evaluating204
the dissimilarity of two action-sequences based on the TPD measure is presented205
in Fig. 2.206
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Figure 2: Calculation of TPD of two action sequences
Selection of clustering algorithm: The TPD measures of each pair of pa-207
tients’ treatments in the given record are used to cluster the similar sequences in208
the same subgroups. The hierarchical density-based spatial clustering of applica-209
tions with noise (hierarchical DBSCAN) algorithm [15] is employed to identify210
the groups of patients’ treatments. The selection of DBSCAN in the present211
context is justified because of its merit of clustering similar data points (here,212
the action-sequences of patients) into same groups based on the density (number213
of nearby neighbors) without prior setting of the number of clusters. Moreover,214
unlike the traditional partitioning algorithms, DBSCAN can be applied for clus-215
ters of arbitrary shape, even when the data may be contaminated with noise216
[16].217
It is however worth mentioning that the huge economic database includes218
clusters of records of patients characterized at di erent density levels. The tra-219
ditional DBSCAN algorithm with a single global density threshold often fails to220
e ectively identify such clusters. This impasse is overcome here by using the221
hierarchical DBSCAN, proposed in [15], which discovers all DBSCAN-identified222
clusters for an infinite range of density thresholds. Finally, it identifies a simpli-223
fied hierarchical structure of significant clusters only.224
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2.3 Markov Chain Representation of a Cluster225
This step is concerned with representing each cluster of patients’ action-sequences226
by a Markov chain [11]. The crux of such representation is founded on the un-227
derlying premise that the medical practitioners take their decision based on the228
previous clinical activities. Again, our cost prediction algorithm greatly relies229
on the recorded action-sequence of a patient.230
A first order Markov chain exhibits memoryless property where the current231
state only depends on the previous state. Let N be the possible number of232
actions (activity-cost pairs) in the database. The Markov chain model of a233
group of patients, say Gl, is then demonstrated by a state-transition probability234
distribution, which is denoted as:235
Ml = [mi,j,l] for i, j = 1, 2, . . . , N (9)




Here qi,j,l and pl(xt+1 = aj |xt = ai) respectively denote the number of cases236
and the probability of transition from the current action xt = ai to the immediate237
next action xt+1 = aj in the specific group Gl of action-sequences. Evidently, it238
satisfies239
mi,j,l Ø 0 and
Nÿ
j=1
mi,k,l = 1. (11)
In addition to Ml, we also evaluate the initial probability pl(ai) of action ai240





Here si,l denotes the number of action-sequences initiated with the action ai242
in Gl for i = 1, 2, . . . , N . This entire process is repeated for all groups identified243
by the hierarchical DBSCAN.244
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2.4 Cost Prediction of a Patient’s Treatment from Action245
Sequence246
The aim of this step is to predict the possible total cost of a patient from the247
respective action-sequence. The action-sequence of the patient is formed follow-248
ing the principle given in Section 2.1. Let the ordered sequence of actions of the249
new patient’s treatment be denoted by P = (a1, a2, . . . , an) where the action ai250
represents the activity-cost pair at the visiting time instant ti. The prediction251
of future cost based on P is undertaken in three phases.252
Phase-1: Cost estimation of P based on a specific group. We employ253
k-nearest neighbor (k-NN) to identify k action-sequences from a group, say Gl,254
that o er maximum similarity with P based on TPD measure as given in (8).255
First, we compute the TPD values between P and each member sequence of256
the group Gl. The member sequences are then sorted in ascending order of their257
TPD measures thus evaluated. The first k members are selected as the k nearest258
neighbors of P . Next, each of the k members is assigned a weight wj,l, inversely259
proportional to its TPD measure from P for j = 1, 2, . . . , k. Consequently, the260




j=1 wj,l ◊ cj,lqk
j=1 wj,l
. (13)
Here cj,l denotes the total cost incurred by the j-th nearest neighbor of P in263
Gl for j = 1, 2, . . . , k. ĉl(P ) is computed for all clusters of patients identified by264
the hierarchical DBSCAN.265
Phase-2: Evaluation of the likelihood of P to patients’ groups. This266
step is concerned with evaluating the likelihood of P to each subgroup of patients267
based on the respective Markov chain model. The likelihood of the ordered268
sequence of actions P = (a1, a2, . . . , an) to a specific group Gl is given by269




Here a1 denotes the initial action of P and ai represents the action of P270
occurred at visiting time ti for i = 1, 2, . . . , n. Evidently, pl(a1) and pl(ai+1|ai)271
respectively symbolize the initial probability of action a1 and the probability of272
transition from the current action ai to the immediate next action ai+1 of P as273
described by the group Gl. Expression (14) is evaluated using the Markov chain274
model Ml representing the group Gl.275
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After evaluating ⁄l(P ) for all groups, the normalized likelihood of P to each276





Phase-3: Cost prediction based on all groups. After evaluating the278
estimated cost and the normalized likelihood of P to all groups, the total cost279




⁄̂l(P ) ◊ ĉl(P ). (16)
3 Results281
3.1 Database282
The study is performed on the economic data, along with the clinical activi-283
ties of the patients obtained from the health administrative department of the284
public health care system (OSAKIDETZA) of the Basque Country, Spain. The285
database includes medical history of 579798 patients treated in di erent lev-286
els of healthcare organizations (including 1 hospital, 11 outpatients clinics and287
emergency care) from January 1, 2017 to December 31, 2019. The clinical data288
of the patients primarily consists of their clinical assistance and the respective289
healthcare cost information.290
To validate the proposed method of cost prediction, the present work con-291
siders the pool of breast cancer patients only. The selection of breast cancer292
patients from the database conforms the International Statistical Classification293
of Diseases and Related Health Problems (10-th revision) [17], stating that ev-294
ery code starting by C50 corresponds to breast cancer diagnosis. A few filtering295
steps are then carried out following [21] to judiciously select the pool of patients296
of interest. The filtering process a rms that the selected patients have their297
complete treatment in the above-mentioned time period of two years. Following298
the medical guideline, a final set of 972 patients is identified. 70% of the entire299
database is ultimately used as the training dataset, while the remaining as the300
test data. A 10-fold cross validation is employed on the training dataset for301
judicious selection of the value of k for k-NN.302
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3.2 Identification and Representation of Patients’ Action-303
Sequences304
The final record of the 464 patients consists of 23 unique clinical activities as305
described in Table 1. The healthcare cost is next discretized into ns segments.306
In Fig. 3, we present a plot of normalized quantization error values for di erent307
settings of the number of quantiles ns, varied from 2 to 12 to check a significant308






i=1 |c(i) ≠ cm(i)|




Here c(i) and cm(i) respectively denote the true and the modified i-th health-311
care cost (after discretization) of the database with Nc cost elements for i = 1,312
2, ..., Nc. Fig. 3 reveals that the quantization error is reduced with an increase313
in the number of segments ns. However, it is also observed that there is no314
significant change in the error for ns Ø 8. We have thus fixed ns = 8. It is worth315
mentioning that the setting of ns here is biased to the healthcare cost values316
of the present database. The quantization of the healthcare cost range of the317
present database using 8-quantiles ensures a balanced number of healthcare cost318
elements in each of the eight cost-segments.319
Figure 3: Normalized quantization error for di erent values of ns
Next, the healthcare cost of all clinical activities of 464 patients is discretized320
in eight segments based on 8-quantiles of the healthcare cost range, as demon-321
strated in Fig. 1. Let the segments (sorted in ascending order) be denoted as322
very-very-low (VVL), very-low (VL), low (L), medium-low (ML), medium-high323
(MH ), high (H ), very-high (VH ) and very-very-high (VVH ). Eventually, there324
exist 22 ◊ 8 = 176 actions to jointly represent a pair of clinical activity and the325
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corresponding healthcare cost. However, a close scrutiny of the final record re-326
veals only 63 possible pairs from the recorded medical history of the 464 patients,327
as reported in Table 2.328
The hierarchical DBSCAN algorithm is then employed on the training dataset329
to cluster the sequences using TPD values. The algorithm results in eight clus-330
ters. The clusters thus identified are pictorially represented in Fig. 4. The331
descriptions of the actions of the sequences, shown in di erent colors, are tab-332
ulated in Table 2. Each cluster is then described by a Markov chain following333
Section 2.3.334
Figure 4: Cluster of sequences of visit records (activity-cost pairs) of patients
with np as number of patients and L as the length of the sequence
3.3 Performance Evaluation of Proposed Healthcare Cost335
Prediction Method336
Performance metric: The performance of the proposed cost prediction algo-337
rithm is evaluated with respect to mean absolute percentage error (MAPE) with338











Here c(Pi) and c̄(Pi) (evaluated using (16)) respectively represent the true340
and the predicted cost of the i-th patient’s treatment Pi in the test dataset with341
Nt records for i = 1, 2, . . . , Nt.342
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Table 1. Description of the clinical activities343
Activity Abbreviated form Full form
1 ANES Aesthesia
2 APAT Pathological Anatomy
3 CEXT External Consultation
4 CONS Consultation
5 FAMB Hospital Pharmacy Services
6 FAMR Pharmacy
7 HCRI Critical Care Hospitalization
8 HDIA Day Hospital




13 MNUC Nuclear Medicine
14 OSAT Osatek (Magnetic Resonance Service)
15 PFUN Functional Testing




20 UCRI Nursing Critical Care Unit
21 UCSI Surgery without Hospitalization
22 UENF Nursing Unit
23 URP Post Anesthesia Care Unit
Validation of Earliness Prediction and Selection of k of k-NN: The344
capability of the proposed algorithm to predict the possible total healthcare cost345
of patients is verified by varying the length of sequence of the recorded treat-346
ments of the patients from 20% to 100%. The appropriate selection of k (of347
k-NN) for the optimal performance is undertaken using 10-fold cross validation348
on the training dataset. The MAPE values for di erent settings of k and per-349
centage of length of sequence of the recorded treatments of the patients using350
10-fold cross validation are tabulated in Table 3 (for the training data). Table351
3 reveals that the longer the length of the sequence, the better is the prediction352
accuracy with smaller MAPE measures, irrespective of the setting of k. The353
optimal performance of the method is obtained for k = 3 with the entire se-354
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quence information. It is also noted that an MAPE smaller than 6% is obtained355
even when 50% of a visit sequence is utilized. It proves the e ectiveness of the356
proposed method for an early prediction of the healthcare cost.357
Table 2A. Description of the clinical actions (activity-cost pairs)358
Action Activity Cost Action Activity Cost Action Activity Cost
1 ANES VVL 26 FAMB L 51 HDIA VVH
2 ANES VL 27 FAMB ML 52 HDOM VVL
3 ANES L 28 FAMB H 53 HDOM VL
4 ANES ML 29 FAMB VH 54 HDOM L
5 ANES MH 30 FAMB VVH 55 HDOM ML
6 ANES H 31 FAMR VVL 56 HDOM H
7 ANES VH 32 FAMR VL 57 HDOM VH
8 ANES VVH 33 FAMR L 58 HDOM VVH
9 APAT VVL 34 FAMR ML 59 HOSP VVL
10 APAT L 35 FAMR MH 60 HOSP VL
11 APAT VH 36 FAMR H 61 HOSP L
12 APAT VVH 37 FAMR VH 62 HOSP ML
13 CEXT VL 38 FAMR VVH 63 HOSP MH
14 CEXT L 39 HCRI VVL 64 HOSP H
15 CEXT ML 40 HCRI VL 65 HOSP VH
16 CEXT H 41 HCRI L 66 HOSP VVH
17 CONS VVL 42 HCRI VH 67 INCO L
18 CONS L 43 HCRI VVH 68 INCO ML
19 CONS ML 44 HDIA VVL 69 INCO MH
20 CONS MH 45 HDIA VL 70 INCO VH
21 CONS H 46 HDIA L 71 INCO VVH
22 CONS VH 47 HDIA ML 72 LABO L
23 CONS VVH 48 HDIA MH 73 LABO MH
24 FAMB VVL 49 HDIA H 74 LABO VH
25 FAMB VL 50 HDIA VH 75 LABO VVH
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Table 2B. Description of the clinical actions (activity-cost pairs)359
Action Activity Cost Action Activity Cost Action Activity Cost
76 MNUC L 91 QUIR MH 106 REHA ML
77 MNUC ML 92 QUIR H 107 REHA MH
78 MNUC H 93 QUIR VH 108 RTER VVL
79 MNUC VH 94 QUIR VVH 109 RTER MH
80 MNUC VVH 95 RADI VVL 110 RTER H
81 OSAT L 96 RADI VL 111 RTER VH
82 OSAT H 97 RADI L 112 RTER VVH
83 OSAT VH 98 RADI ML 113 UCRI VVH
84 OSAT VVH 99 RADI MH 114 UCSI VH
85 PFUN VVL 100 RADI H 115 UENF MH
86 PFUN VL 101 RADI VH 116 UENF H
87 PFUN L 102 RADI VVH 117 UENF VH
88 QUIR VL 103 REHA VVL 118 UENF VVH
89 QUIR L 104 REHA VL 119 URP ML
90 QUIR ML 105 REHA L
Comparative performance analysis: The next experiment aims at com-360
parative performance analysis of our proposed algorithm. Three state-of-the-361
art techniques are considered in the comparative framework, including gradient362
boosting (GB) [18], artificial neural net (ANN) [19] and lasso [20]. These existing363
methods have utilized the healthcare cost data only to predict the future cost364
[2]. The MAPE measures for these algorithms are tabulated in Table 4. The re-365
ported results substantiate that our proposed method overcomes its contenders366
with GB acquiring the second rank. It in turn validates the e ciency of jointly367
considering the clinical activity and the associated cost data for the healthcare368
cost prediction.369
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Table 3. MAPE values (training error during 10-fold cross validation) for dif-370
ferent values of k and length of sequence (in percentage per)371
per
k
20% 30% 40% 50% 60% 70% 80% 90% 100%
1 9.25 7.43 6.01 6.50 5.85 5.53 4.68 4.15 3.76
2 8.83 8.08 6.95 6.54 6.04 5.80 5.15 4.10 3.65
3 8.87 7.74 5.89 5.39 4.98 4.62 4.38 4.07 3.49
4 9.36 7.82 6.04 5.47 4.86 4.65 3.94 3.77 3.63
5 8.90 7.14 5.69 5.13 4.84 4.49 4.24 3.77 4.03
6 9.01 7.35 5.76 5.32 5.17 5.15 4.51 4.26 4.33
7 9.29 7.58 5.77 5.27 5.58 4.97 4.62 4.46 4.35
8 9.13 7.39 5.72 5.64 5.18 5.28 4.46 4.13 4.21
9 9.57 7.66 5.92 5.42 5.57 5.14 4.64 4.11 4.08
10 9.68 8.51 6.27 6.26 6.11 5.93 5.22 4.60 4.41
Table 4. MAPE values (with test data) for di erent competitive methods for372
di erent length of sequence (in percentage per)373
per 20% 30% 40% 50% 60% 70% 80% 90% 100%
Prop.
method
8.89 7.84 6.27 6.05 5.94 5.53 5.29 4.17 3.59
GB 9.70 8.63 6.41 6.37 6.57 5.91 5.55 4.94 4.43
ANN 10.89 10.69 9.83 9.45 8.58 7.98 7.55 6.95 6.61
LASSO 12.08 11.93 11.86 10.80 9.85 9.32 8.85 8.12 7.65
4 Conclusion374
The paper presents a novel method to predict healthcare cost of breast cancer375
patients as early and accurately as possible. The early prediction capability of376
the proposed method is used for identifying patients at risk of becoming high-377
cost healthcare users, before incurring substantial avoidable costs. The merit of378
the paper lies in the following counts. First, it considers the clinical activity and379
the associated healthcare cost data jointly to model the treatment of a patient.380
Second, it recommends a novel distance measure to capture the dissimilarity of381
two treatment patterns, encompassing both clinical activities and healthcare cost382
information. Third, it employs the hierarchical DBSCAN to categorize patients383
into di erent clusters with an aim to e ectively identify the high-need and/or384
high-cost patients. Fourth, each cluster of patients is depicted by a Markov chain385
model to mathematically represent the treatment patterns. Finally, the Markov386
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chain models of all the clusters are used to predict the possible future (total)387
cost of a patient’s treatment. The performance of the proposed algorithm is388
compared for di erent length of sequence of the recorded treatments of patients.389
The experimental results reveal that the method achieves an MAPE value, as390
small as 6% even with half of the clinical records of a patient. Experiments391
undertaken also substantiate the superiority of the proposed algorithm to three392
state-of-the-art techniques which utilize only the healthcare cost data of the393
patients for prediction.394
As a continuation of the present work, we first plan to test our method on395
di erent databases from di erent healthcare organizations for patients su ering396
from di erent diseases. More experiments on di erent databases could help to397
take a deeper dive into the data and explore ways to obtain more solid evidence398
on the performance of the proposed method, irrespective of databases. Second,399
we may consider the socio-demographic information of the patients along with400
the clinical actions with an aim to be utilize their joint explanatory power to401
understand the root causes of patient’ costs. Third, we have not exploited time402
feature in the present work. Intuitively, inclusion of time feature may e ec-403
tively capture the di erences of treatment patterns of patients and thus may404
enhance the prediction performance of the proposed method. Finally, appropri-405
ate stratagem needs to be developed to e ectively balance the trade-o  between406
the accuracy and earliness of the healthcare cost prediction.407
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